Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer of Head and Neck: early-phase trial registry
1 of 10 indexed Cancer of Head and Neck trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 1 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Cancer of Head and Neck: 10 US clinical trials tracked, 1 recruiting.
Cancer of Head and Neck is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Beth Israel Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition cancer-of-head-and-neck
OPEN 1 | RECR 10% | LATE 0 | EARLY 3 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Angina Pectoris (10% recruiting · 10 trials)
Cancer of Head and Neck lists 1 open slots (10% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer of Head and Neck on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer of Head and Neck is recruiting below its size-band peers.
1 of 10 indexed trials (10%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer of Head and Neck trials is spread across many organizations.
Beth Israel Medical Center accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Cancer of Head and Neck trials plan to enrol fewer than 100 people.
Median target enrolment is 20 among the 10 trials that report a genuine target (sentinel values excluded). 7 of those (70%) plan for fewer than 100 participants.
-
Cancer of Head and Neck research is mostly interventional.
9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics
NCT04510129
Onco-primary Care Networking to Support TEAM-based Care
Duke University
NCT04258813
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Loren Mell, MD
NCT03383094
A Comprehensive Approach to Head and Neck Cancer Prehabilitation
Sanford Health
NCT04617678
The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery
University of Alabama at Birmingham
NCT05061316
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
Dartmouth-Hitchcock Medical Center
NCT02648178
Single-arm Phase II Study of NDURE for Patients With HNC
Medical University of South Carolina
NCT03821064
Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer
Dana-Farber Cancer Institute
NCT02865135
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
NCT03993353
Adaptive Radiation Therapy for Head & Neck Cancer Patients
Beth Israel Medical Center
NCT01853670
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cancer of Head and Neck records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer of Head and Neck trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer of Head and Neck page
10 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cancer of Head and Neck trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Beth Israel Medical Center sponsors the most Cancer of Head and Neck trials on record, review their full trial history before evaluating a specific study. See Beth Israel Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer of Head and Neck condition card totals 10 registered trials; most-linked intervention Pembrolizumab; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.